All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for THE HEMOPHILIA ALLIANCE · Nonprofit membership organization for federally-funded hemophilia treatment centers

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $30,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 3

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 6423
HELP Copays Act
HR 9599
SECURE 340B Act

Lobbying activity 4

Medicare/Medicaid

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements

Insurance

Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs

Pharmacy

Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599

Budget/Appropriations

Funding for federal hemophilia programs at CDC and HRSA for FY27 Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.